![David Zaccardelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Zaccardelli
Président chez
SAB BIOTHERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
David S.
Zaccardelli is the founder of Bull City Select Investments LLC.
Current positions include Chairman at SAB Biotherapeutics, Inc. starting in 2026, Director at Elucida Oncology, Inc. since 2021, Director at Evecxia, Inc. since 2016, and Independent Director at Vor Biopharma, Inc. starting in 2026.
Former roles include Chief Executive Officer & Director at Cempra, Inc. from 2016 to 2017, President, Chief Executive Officer & Director at Dova Pharmaceuticals, Inc. from 2018 to 2019, President, CEO & Executive Director at Verona Pharma Ltd. from 2020 to 2025, Director at CoreRx, Inc. from 2015 to 2021, Director-Clinical & Scientific Affairs at Bausch & Lomb Pharmaceuticals, Inc. from 1996 to 1997, Independent Director at Melinta Therapeutics, Inc. from 2016 to 2020, and Chief Operating Officer & Executive Vice President at United Therapeutics Corp.
from 2015 to 2016.
Education includes a doctorate from the University of Michigan conferred in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VOR BIOPHARMA, INC. -.--% | 07/07/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de David Zaccardelli
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Président | 05/01/2026 |
| VOR BIOPHARMA INC. | Directeur/Membre du Conseil | 06/07/2026 |
Evecxia, Inc.
 Evecxia, Inc. Pharmaceuticals: MajorHealth Technology Produces natural brain serotonin to treat mental illnesses | Directeur/Membre du Conseil | 01/06/2016 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Directeur/Membre du Conseil | 29/04/2021 |
Bull City Select Investments LLC
 Bull City Select Investments LLC Financial ConglomeratesFinance Provides investment services | Fondateur | - |
Anciens postes connus de David Zaccardelli
| Sociétés | Poste | Fin |
|---|---|---|
CoreRx, Inc.
 CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in drug development and manufacturing of solid, liquid & semi-solid dosage forms | Directeur/Membre du Conseil | 01/01/2021 |
| MELINTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/04/2020 |
| DOVA PHARMACEUTICALS, INC. | Directeur Général | 12/11/2019 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Directeur Général | 01/11/2017 |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Zaccardelli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
United Therapeutics Corp.
 United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in drug development and manufacturing of solid, liquid & semi-solid dosage forms | Commercial Services |
Bausch & Lomb Pharmaceuticals, Inc.
 Bausch & Lomb Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets eye health products | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Bull City Select Investments LLC
Bull City Select Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Evecxia, Inc.
Evecxia, Inc. Pharmaceuticals: MajorHealth Technology Produces natural brain serotonin to treat mental illnesses | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Choisissez Zonebourse 
